Brian R Bonfardin is a Greeneville, Tennessee based psychiatrist who is specialized in Psychiatry. His current practice location is 401 Takoma Ave, Greeneville. Patients can reach him at 423-639-3151 or can fax him at 423-798-1266. Brian R Bonfardin is MD in Psychiatry and his NPI number (Unique professional ID assigned by NPPES) is 1356322515. Brian R Bonfardin specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.
Complete Profile:
Brian R Bonfardin speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1356322515
NPI Enumeration Date:
07 Nov, 2005
NPI Last Update On:
08 Jul, 2007
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Brian R Bonfardin 401 Takoma Ave, Greeneville, Tennessee
Zip:
37743-4647
Phone Number:
423-639-3151
Fax Number:
423-798-1266
Patients can reach Brian R Bonfardin at 401 Takoma Ave, Greeneville, Tennessee or can call to book an appointment on 423-639-3151.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.